Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer

Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer

Development of aromatase inhibitor resistant breast cancer among postmenopausal women continues to be a major clinical obstacle. Previously, our group demonstrated that as breast cancer cells transition from hormone-dependent to hormone-independent, they are associated with increased growth factor s...

Full description

Bibliographic Details
Main Authors: Karen M. Gallegos, Jankiben R. Patel, Shawn D. Llopis, Rashidra R. Walker, A. Michael Davidson, Wensheng Zhang, Kun Zhang, Syreeta L. Tilghman
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
aromatase inhibitors
breast cancer
cancer stem cells
letrozole resistance
translation
midasin
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.540134/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.540134/full

Similar Items